TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Quantum Biopharma ( (TSE:QNTM) ).
Quantum Biopharma Ltd. released its unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2025, showing a decrease in total assets from $17.1 million in 2024 to $14.2 million in 2025. The report highlights a significant increase in digital assets and a reduction in cash and cash equivalents, indicating a strategic shift in asset allocation. The financial results may impact the company’s operational strategies and stakeholder confidence.
More about Quantum Biopharma
Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., operates in the biopharmaceutical industry. The company focuses on the development of innovative therapies and pharmaceutical products.
Average Trading Volume: 3,599
Technical Sentiment Signal: Sell
Current Market Cap: C$47.33M
Find detailed analytics on QNTM stock on TipRanks’ Stock Analysis page.